Helbling Peter, Medinger C, Altpeter Ekkehart, Raeber Pierre-Alain, Beeli D, Zellweger Jean-Pierre
Swiss Federal Office of Public Health, Bern.
Swiss Med Wkly. 2002 Sep 7;132(35-36):517-22. doi: 10.4414/smw.2002.10045.
Adequate treatment of pulmonary tuberculosis cures patients and reduces transmission. The study assesses treatment outcomes under current conditions in Switzerland.
Retrospective cohort study including all TB cases with positive sputum cultures notified to the national surveillance system between July 1996 and June 1997. Ten months after notification, treating physicians reported the outcomes using WHO categories.
Of 265 patients, 209 (79%) completed at least 6 months' treatment, 3 (1%) were treatment failures, 23 (9%) died, 8 (3%) defaulted from treatment and 22 (8%) left the country. The proportion of successful treatments did not significantly differ between the 103 Swiss-born (80%) and the 162 foreign-born (78%) patients. There were 19 deaths (18%) in the Swiss-born and 4 (2%) in the foreign-born groups; death was caused by TB in two patients, 10 died of other causes (cause unknown in 11). In the foreign-born group there were 31 (19%) potentially unsatisfactory outcomes (treatment failure, default from treatment, transfer abroad) and in the Swiss-born group 2 (2%). Default from treatment involved 8 patients, 6 of whom were asylum seekers. In a multivariate analysis potentially unsatisfactory outcomes were not significantly associated with foreign origin but with status as a foreigner of irregular or unknown legal status (adj. OR 8.8; 95% CI 1.4 to 53.7).
Overall treatment success rates are satisfactory and similar to those of other western European countries. Potentially unsatisfactory outcomes are more common in foreign-born persons of irregular legal status. Tracking of non-adherent patients by health workers could further improve outcomes.
对肺结核进行充分治疗可治愈患者并减少传播。本研究评估了瑞士当前条件下的治疗效果。
回顾性队列研究,纳入1996年7月至1997年6月间向国家监测系统报告的所有痰培养阳性的结核病病例。报告后10个月,治疗医生使用世界卫生组织的分类标准报告治疗结果。
265例患者中,209例(79%)完成了至少6个月的治疗,3例(1%)治疗失败,23例(9%)死亡,8例(3%)中断治疗,22例(8%)离开该国。103例瑞士出生的患者(80%)和162例外国出生的患者(78%)的成功治疗比例无显著差异。瑞士出生组有19例死亡(18%),外国出生组有4例死亡(2%);2例患者死于结核病,10例死于其他原因(11例原因不明)。外国出生组有31例(19%)潜在的不理想结局(治疗失败、中断治疗、转至国外),瑞士出生组有2例(2%)。中断治疗的有8例患者,其中6例是寻求庇护者。多因素分析显示,潜在的不理想结局与外国国籍无显著关联,但与非法或法律地位不明的外国人身份有关(校正比值比8.8;95%可信区间1.4至53.7)。
总体治疗成功率令人满意,与其他西欧国家相似。潜在的不理想结局在非法法律地位的外国出生者中更为常见。卫生工作者对不依从患者的追踪可进一步改善治疗效果。